Anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents: Analysis of data reported to EudraVigilance

AIM: The present study aimed to estimate the anaphylaxis rates following mRNA COVID-19 vaccination in children and adolescents in Europe. METHODS: We retrieved data on 371 anaphylaxis cases following mRNA COVID-19 vaccination in children ≤ 17 years old notified to EudraVigilance as of October 8, 202...

Descripción completa

Detalles Bibliográficos
Autores principales: Maltezou, Helena C., Hatziantoniou, Sophia, Theodoridou, Kalliopi, Vasileiou, Konstantinos, Anastassopoulou, Cleo, Tsakris, Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968615/
https://www.ncbi.nlm.nih.gov/pubmed/36872145
http://dx.doi.org/10.1016/j.vaccine.2023.02.067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968615/
https://www.ncbi.nlm.nih.gov/pubmed/36872145
http://dx.doi.org/10.1016/j.vaccine.2023.02.067

Ejemplares similares